St. Jude Medical Gets FDA OK for Merlin (AP via Yahoo! Finance)
Heart device maker St. Jude Medical Inc. said Monday that the Food and Drug Administration approved a new programmer for its implantable defibrillators and pacemakers.

Bruker BioSciences Corporation Announces Agreement to Acquire Bruker Optics Inc. for $135 Million in Cash and Stock (Business Wire via Yahoo! Finance)
BILLERICA, Mass.----April 17, 2006--Bruker BioSciences Corporation today announced that it has entered into a definitive agreement to acquire all of the stock of molecular spectroscopy company Bruker Optics Inc. for $135 million, to be paid approximately 59% in cash and 41% in BRKR stock.

Supplemental Biologics License Application For Avastin(R) With Chemotherapy In First-Line, Non-Squamous, Non-Small Cell (Medical News Today)
Genentech, Inc. (NYSE: DNA) announced today that the company submitted asupplemental Biologics License Application (sBLA) with the U.S. Food andDrug Administration (FDA) for Avastin(R) (bevacizumab) in combination withplatinum-based chemotherapy for first-line treatment of advanced, non-squamous, non-small cell lung cancer (NSCLC)... click link for more info.